Jupiter Neurosciences (JUNS) Current Assets (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported Current Assets for 4 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets fell 9.59% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $2.5 million, a 9.59% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, up 3.76% from the prior year.
• Current Assets was $2.5 million for Q2 2026 at Jupiter Neurosciences, down from $4.8 million in the prior quarter.
• Over five years, Current Assets peaked at $4.8 million in Q4 2025 and troughed at $514.0 in Q3 2024.
• A 4-year average of $2.5 million and a median of $2.7 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 317479.38% in 2025 and retreated 9.59% in 2026, its largest moves.
• Over 4 years, Current Assets stood at $28739.0 in 2023, then surged by 16081.02% to $4.7 million in 2024, then increased by 3.76% to $4.8 million in 2025, then plunged by 47.17% to $2.5 million in 2026.
• The last three Current Assets figures came in at $2.5 million (Q2 2026), $4.8 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.